Xeno Transplants Corporation
XENO · OTC
3/31/2008 | 12/31/2007 | 9/30/2007 | 6/30/2007 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.26 | -1.63 | -1.32 | -0.52 |
| FCF Yield | -4.26% | -0.59% | -0.32% | -1.20% |
| EV / EBITDA | -41.20 | -132.40 | -242.00 | -506.64 |
| Quality | ||||
| ROIC | 21.36% | 37.66% | 44.97% | 22.48% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.49 | 0.14 | 0.19 | 1.18 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | -30.39% | -21.62% | 79.42% | -1,897.84% |
| Safety | ||||
| Net Debt / EBITDA | -4.38 | -1.81 | 0.03 | 0.37 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |